comparemela.com

Have Recently News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update

     Third Quarter 2023 Total Net Revenues of $102.7 Million, a 79.4% Increase YOY Third Quarter 2023 GAAP Net Loss per Share of $ Diluted, Impacted by an $81.5 Million One Time Non-Recurring.

vimarsana © 2020. All Rights Reserved.